A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

2-Bromoadamantane | CAS 7314-85-4 - Request Quote

Picture of 2-Bromoadamantane

2-Bromoadamantane

SZ CAT No:SZ-A002029
CAS No
7314-85-4
Mol.F.
C10H15Br
Mol.Wt.
215.1
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

2-Bromoadamantane is chemically (1r,3r,5r,7r)-2-Bromoadamantane. 2-Bromoadamantane is supplied with detailed characterization data compliant with regulatory guideline. 2-Bromoadamantane can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Adapalene.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 7314-85-4

Purchase 7314-85-4

Order 7314-85-4

Enquire 7314-85-4

price of 7314-85-4

7314-85-4 Supplier

7314-85-4 Manufacturer

7314-85-4 Exporter

buy high quality 2-Bromoadamantane

Purchase 2-Bromoadamantane

2-Bromoadamantane suppliers

2-Bromoadamantane manufacturers

2-Bromoadamantane price

Order 2-Bromoadamantane

Enquire 2-Bromoadamantane

2-Bromoadamantane cost

2-Bromoadamantane Supplier

2-Bromoadamantane Distributor

2-Bromoadamantane for Method Validation

Adapalene Reference Standard

2-Bromoadamantane for ANDA Filing

2-Bromoadamantane for Forced Degradation Studies

2-Bromoadamantane Identification Standards

2-Bromoadamantane for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,